Physician

Adheesh Agnihotri, M.D.

According to 2025 Medicare claims, Adheesh Agnihotri, M.D. (NPI: 1407873490) practices cardiac electrophysiology in the Orlando-Kissimmee-Sanford, FL market, with the plurality of this provider's patient population coming from Lake, FL. This provider's primary affiliated billing organization is CARDIOVASCULAR INSTITUTE OF CENTRAL FLORIDA, LLC (NPI: 1679666598; TIN: 20-5476847) and primary practice location at 34711-1957. Agnihotri is affiliated with the MaineHealth Accountable Care Organization (ACO ID: A1290), participating under the MSSP model.

Agnihotri's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 542 traditional Medicare patients, billed 2,101 HCPCS/CPT codes, and received $215,500 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 1,163 prescription claims across 328 beneficiaries totaling $394,956 in drug costs, led by Eliquis (Apixaban). Open Payments data shows 41 records totaling $14,126. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $16,834 to $215,500. Similarly, Part D prescription costs have moved sharply higher in recent years, from $9,466 to $394,956. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	374	562	$16,834
2016	1,063	2,002	$83,701
2017	981	1,850	$86,626
2018	1,306	2,584	$113,283
2019	1,258	2,295	$101,862
2020	980	1,898	$94,085
2021	378	1,092	$96,842
2022	595	2,200	$171,688
2023	1,208	4,037	$267,306
2024	542	2,101	$215,500

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	62	142	$9,466
2016	162	1,038	$114,994
2017	192	1,416	$185,320
2018	208	1,232	$243,865
2019	188	684	$187,940
2020	162	612	$193,338
2021	121	279	$89,454
2022	165	550	$138,507
2023	347	1,315	$450,760
2024	328	1,163	$394,956

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	98	131	$130
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	218	396	$91
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	77	123	$61
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	157	212	$13
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	203	331	$10

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	218	12,610	$244,333
Xarelto	Rivaroxaban	40	2,880	$51,518
Multaq	Dronedarone Hcl	20	1,245	$31,580
Dofetilide	Dofetilide	78	5,445	$21,623
Flecainide Acetate	Flecainide Acetate	93	7,155	$2,878

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	41	$14,126	BIOTRONIK INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Adheesh Agnihotri, M.D.?

Tedicare shows public-source Medicare data for Adheesh Agnihotri, M.D. (NPI 1407873490), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Adheesh Agnihotri, M.D. have ACO affiliation data?

Adheesh Agnihotri, M.D. is shown with ACO affiliation data for MaineHealth Accountable Care Organization (MSSP, ACO ID A1290).

What billing organization is linked to Adheesh Agnihotri, M.D.?

Adheesh Agnihotri, M.D. is linked to CARDIOVASCULAR INSTITUTE OF CENTRAL FLORIDA, LLC (billing NPI 1679666598) in the available physician profile data.

Does Adheesh Agnihotri, M.D. have Open Payments data?

Adheesh Agnihotri, M.D. has 41 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.